New Key Statistics Module, Z-Score and F-Score
NAS:NRIX Key Ratios
| Market Cap $ M | 1,484.69 |
| Enterprise Value $ M | 1,070.37 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.00 |
| Price/Sales | 20.71 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 62.00 |
| EPS (TTM) $ | -2.92 |
| Beneish M-Score | -3.34 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -43.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.98 |
| EV-to-EBITDA | -6.53 |
| PEG | -- |
| Shares Outstanding M | 64.41 |
| Net Margin (%) | -264.84 |
| Operating Margin % | -287.47 |
| Pre-tax Margin (%) | -264.55 |
| Quick Ratio | 5.57 |
| Current Ratio | 5.57 |
| ROA % (ttm) | -44.88 |
| ROE % (ttm) | -66.87 |
| ROIC % (ttm) | -149.27 |
| Dividend Yield % | -- |
| Altman Z-Score | 4.54 |
NRIX Number of Guru Trades
NRIX Volume of Guru Trades
Gurus Latest Trades with NAS:NRIX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:NRIX is held by these investors
Total 1
Nurix Therapeutics Inc Insider Transactions
No Available Data
News about NAS:NRIX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers